---
title: Receptor effects and psychedelics
videoId: GzvzWO0NU50
---

From: [[hubermanlab]] <br/> 
Psychedelics have been a topic of intense scientific and cultural interest due to their profound impact on human perception and cognition. At the heart of these effects are the intricate interactions between psychedelics and various receptor systems in the brain. In this article, we delve into how different classes of psychedelics exert their influence primarily through receptor-level interactions, highlighting their profound effects on human behavior and perception.

## What is a Psychedelic?

Dr. Matthew Johnson, a leading expert on psychedelics, describes psychedelics as substances that can profoundly alter one's sense of reality, including [[understanding_the_structure_and_function_of_self | altering the perception of self]] during their acute effects. This broad definition encompasses several classes of compounds, each interacting with distinct receptor systems in the brain <a class="yt-timestamp" data-t="00:08:00">[00:08:00]</a>.

### Classes of Psychedelics

- **Classic Psychedelics**: This group includes LSD, [[psilocybin_and_its_effects_on_consciousness | psilocybin (found in "magic mushrooms")]], DMT, and mescaline. These substances are known for their ability to bind to and activate serotonin 2A receptors, a subtype of serotonin receptor, playing a crucial role in [[neuroscience_of_psychedelics_and_their_effects_on_brain_state_and_empathy | altering sensory perception and cognition]] <a class="yt-timestamp" data-t="00:09:00">[00:09:00]</a>.

- **NMDA Antagonists**: Compounds such as [[ketamine_clinical_uses_and_risks | ketamine]] and PCP belong to this class. They interact primarily by blocking NMDA receptors, a subtype of glutamate receptor, leading to [[mechanisms_of_ketamine_in_the_brain | dissociative states]] and unique alterations in sensory perception and cognition <a class="yt-timestamp" data-t="00:09:56">[00:09:56]</a>.

- **Other Classes**: These include less common mechanisms such as kappa-opioid receptors involved with [[cannabis_influence_on_creativity_and_cognition | Salvinorin A from Salvia divinorum]]. Another significant compound is MDMA, often noted for its unique effect of releasing serotonin rather than primarily acting at the receptor level like classic psychedelics <a class="yt-timestamp" data-t="00:12:00">[00:12:00]</a>.

## Receptor-Level Mechanisms

### Classic Psychedelics and Serotonin

Classic psychedelics largely exert their effects through serotonin 2A receptor agonism. By binding to this receptor, they can change the signaling and connectivity of neural circuits that underlie perception and mood. This interaction often results in altered states of consciousness characterized by changes in sensory perception, mood, and thought processes <a class="yt-timestamp" data-t="00:22:00">[00:22:00]</a>.

### NMDA Antagonism and Dissociation

NMDA receptor antagonists like ketamine work by blocking this receptor's activity, leading to dissociative and often hallucinogenic states. The blockade of NMDA receptors can result in altered cognitive and perceptual processing, providing [[therapeutic_potential_of_psychedelics_for_trauma_and_brain_injury | therapeutic potential in conditions like depression and PTSD]] through its rapid-acting antidepressant effects <a class="yt-timestamp" data-t="00:23:00">[00:23:00]</a>.

### MDMA's Serotonin Release

MDMA, while structurally related to amphetamines, primarily works by [[mdma_and_its_potential_therapeutic_uses | increasing serotonin release]], hence differing from other psychedelics that [[role_of_dopamine_and_serotonin_in_depression | directly activate serotonin receptors]]. This massive release of serotonin can lead to feelings of [[role_of_empathy_in_communication | empathy]] and emotional closeness, enabling therapeutic work especially in trauma settings, allowing reprocessing of memories without the usual emotional barriers <a class="yt-timestamp" data-t="00:13:00">[00:13:00]</a>.

## Implications for Therapy

These receptor interactions underpin the potential therapeutic effects of psychedelics. For instance, the [[neuroplasticity_and_memory_formation | alteration in neural plasticity observed following psychedelic use]] may stem from these receptor-level interactions, leading to lasting changes in mood and cognition <a class="yt-timestamp" data-t="02:20:00">[02:20:00]</a>.

### Future Directions

Understanding the receptor dynamics offers a pathway for developing new therapeutic approaches and imbuing old treatments with a stronger scientific basis, shedding light on why certain psychedelics might be effective in treating psychiatric disorders where other treatments have failed <a class="yt-timestamp" data-t="02:10:00">[02:10:00]</a>.

> [!info] Receptor Effects
> 
> Psychedelics exert their powerful effects largely through the serotonin, [[role_of_neurotransmitters_in_adhd_and_addiction | NMDA, and other receptor systems]], potentially paving the way for novel psychiatric treatments.

In conclusion, the receptor-level effects of psychedelics provide a fascinating insight into how such compounds can profoundly alter human perception and emotion. As research progresses, these insights continue to fuel interest in their potential therapeutic applications.